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Background: Little is known about the influence of alcohol
consumption on the disease course in IBD.
Methods: Frequency of alcohol consumption was screened at
enrolment in the Swiss IBD cohort study. Socio-demographic
variables, disease characteristics and course were compared
among non-drinkers (ND), low-to-moderate (LMD) and heavy
drinkers (HD) Results: 43% of 2019 patients reported regular
alcohol consumption: 40.5% LMD and 2.6% HD. Drinkers were
older, mostly males, with a higher body mass index and
concomitant tobacco consumption (p<0.001). The proportion of
ND was significantly higher in CD than UC (60% vs. 52%,
p=0.003). In UC LMD seem to have less extended disease
(59% vs. 48% in ND and 44% in HD; p=0.028). And drinkers
had to be less hospitalized (16% vs. 22% in ND). However, this
could be associated with the protective effect of smoking. HD
received significantly less immunosuppressants. During follow-
up (6925 patient-years) HD with CD seem to have a milder
disease course with only 2.7 surgeries per 100 patient-years
compared to 6.5 and 7.2 in LMD and ND, respectively. The
incidences of abscesses and fistulas were also reduced
compared to ND and LMD (0.9 vs. 2.8 and 3.3 per 100 patient-
years). Conclusions: 43% of the Swiss IBD cohort patients
drink alcohol, among them 6% heavily. Older age, Male gender
and smoking are associated with increased alcohol
consumption. Alcohol may favour a milder course of UC with a
shorter extend, less immunosuppressant use and fewer
hospitalisations. This might be confounded by smoking. Heavy
drinking seemed to reduce the development of abscesses and
fistulas and the need for surgery in CD during follow-up.
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Background: Capsule endoscopy is laborious and costly.
Therefore, we examined the diagnostic value of fecal
calprotectin to increase diagnostic yield.
Methods: We performed a post-hoc analysis of a prospective
cohort of 70 consecutive patients who had received capsule
endoscopy (Pillcam, Given Imaging) after negative bidirectional
endoscopy. Calprotectin (Bühlmann, Switzerland) was
measured in stool samples collected within 24 hours before the
investigation. Primary endpoint was the presence of mucosal
breaks (erosion, ulcer, tumor). Investigators were blinded to
calprotectin results.
Results: Indications for capsule endoscopy were anemia
(51.4%), hematochezia (14.3%), suspected Crohn’s disease
(14.3%), abdominal pain (10%), suspected malignant disease
(8.6%) and unexplained diarrhea (1.4%). The prevalence of
mucosal breaks was 48.6% (n=34) but 4 patients had significant
lesions strictly outside the small bowel and were not included in
the analysis. Calprotectin testing was more often positive
(>50ug/g) in patients with mucosal findings (61.4% vs. 38.6%,
P=0.001) and Receiver Operating Characteristics analysis
showed an area under the curve of 0.760 (95% confidence
interval 0.639-0.857) for fecal calprotectin to identify intestinal
inflammation. At the optimal cut-off (63ug/g), fecal calprotectin
had 90.0% sensitivity and 63.9% specificity. This translated into
a positive and negative likelihood ratio of 2.49 and 0.16,
respectively, and resulted in a high negative predictive value
(88.5%). The overall accuracy was 69.7%.
Conclusion: Fecal calprotectin is a valid marker of intestinal
inflammation in the small bowel and might help to guide
diagnostic investigations.
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Introduction: Hepatitis E virus (HEV) is believed to be the most
common cause of acute hepatitis and jaundice in the world.
However, current knowledge of the molecular virology of
hepatitis E is scarce. The HEV positive-strand RNA genome
harbours 3 open reading frames (ORFs). ORF1 encodes the
functional domains required for viral RNA replication. It is
unclear whether these are processed into distinct proteins or
act as a polyprotein with multiple functions.
Methods: Using specific antibodies directed against functional
ORF1 domains, we investigated putative polyprotein processing
i) in a wheat germ-based cell-free expression system, ii) in
newly established human cell lines inducibly expressing HEV
ORF1, and iii) in selectable subgenomic HEV replicons derived
from the HEV genotype 3 Kernow-C1 strain. The latter system
is currently also being exploited to evaluate novel antiviral
approaches against hepatitis E.
Results: The product of HEV ORF1 was detected only as a
polyprotein in the three experimental systems investigated,
including in a context of genuine viral RNA replication. These
results indicate that no or only very inefficient processing of the
polyprotein encoded by ORF1 occurs during viral replication.
Conclusion: HEV may be unique among positive-strand RNA
viruses in expressing a large polyprotein comprising all
necessary functions to exert RNA replication. Efforts are
ongoing to validate these findings in a fully infectious system. If
confirmed, our findings yield a number of intriguing questions
regarding the functional organization, structure and cell biology
of the polyprotein encoded by HEV ORF1.
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Background: Regular surveillance of patients at risk for
hepatocellular carcinoma (cirrhotics) has been recommended
by European, American and Asian guidelines and is practiced
in many Swiss hepatology clinics. The effectiveness and costs
of 6 monthly surveillance by ultrasonography (US) in
Switzerland is not known.
Methods: In the two-year period 2011/2012, 693 US-
examinations in 283 patients were performed at the Clinic for
Gastroenterology and Hepatology of the University Hospital
Basel. The clinical charts, US reports and reports of additional
examinations (CT, MRI, liver biopsy) were reviewed. The
tumour stage of HCCs detected in the surveillance program
was compared to HCCs not detected in a surveillance
program. The number needed to survey (NNS) to detect an
HCC and the costs per detected HCC were calculated.
Results: No focal lesions were detected in 198 of the 283
patients. In 63 patients, focal lesions that were not HCCs were
detected by the program or known already. In 12 patients no
definitive assessment of a lesion was possible and 3 were lost
to follow-up. In 7 patients, a new HCC was detected. All 7
newly diagnosed HCCs were at an early stage (BCLC 0 or A)
and 5 were within the Milan-Criteria. In non-surveyed patients
with a diagnosis of HCC during the same observation period,
only 33% were diagnosed in an early HCC stage. NNS were 41
patients or 99 US-examinations. The estimated costs per
detected HCC were 12’570 CHF.
Conclusions: In this retrospective analysis, HCC surveillance
resulted in the detection of HCCs in an early stage in all
surveillance patients. The number needed to survey and the
costs of the surveillance are reasonably low. HCC surveillance
should be recommended to all patients at risk for HCC in
whom potentially curative treatments would be used.
